Perimenstrual asthma exacerbations and positioning of leukotriene-modifying agents in asthma management guidelines.
Dean
N L
NL
D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D020024:Leukotriene Antagonists; D011293:Premenstrual Syndrome / Q000188:drug therapy* / Q000209:etiology
D018927:Anti-Asthmatic Agents; D020024:Leukotriene Antagonists